Cargando…

Pulmonary Hypertension in Elderly Patients with Diastolic Dysfunction and Preserved Ejection Fraction

PURPOSE: Patients with diastolic dysfunction may have a disproportionate degree of elevation in pulmonary pressure, particularly in the elderly. Higher pulmonary vascular resistance in the elderly patients with heart failure but preserved ejection fraction suggests that beyond the post-capillary con...

Descripción completa

Detalles Bibliográficos
Autores principales:	Afshar, Majid, Collado, Fareed, Doukky, Rami
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263443/ https://www.ncbi.nlm.nih.gov/pubmed/22282715 http://dx.doi.org/10.2174/1874192401206010001

Ejemplares similares

Diastolic Dysfunction With Preserved Ejection Fraction After the Fontan Procedure
por: Chowdhury, Shahryar M., et al.
Publicado: (2022)

Impact of Updated Guidelines on Diastolic Dysfunction in Patients with Preserved Ejection Fraction
por: Yoon, Hyun Ju
Publicado: (2021)

Diastolic dysfunction in individuals with and without heart failure with preserved ejection fraction
por: Wenzel, Jan-Per, et al.
Publicado: (2021)

NADPH Oxidases in Diastolic Dysfunction and Heart Failure with Preserved Ejection Fraction
por: Teuber, James P., et al.
Publicado: (2022)

Reduced First-Phase Ejection Fraction and Sustained Myocardial Wall Stress in Hypertensive Patients With Diastolic Dysfunction: A Manifestation of Impaired Shortening Deactivation That Links Systolic to Diastolic Dysfunction and Preserves Systolic Ejection Fraction
por: Gu, Haotian, et al.
Publicado: (2017)

Myocardial strain for heart failure with preserved ejection fraction but without diastolic dysfunction
por: Park, Jin Joo, et al.
Publicado: (2022)

Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction
por: Nolte, Kathleen, et al.
Publicado: (2019)

A Case of Postpartum Pulmonary Edema With Preserved Ejection Fraction and Diastolic Capacity
por: Tanabe, Shohei, et al.
Publicado: (2022)

Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction
por: Dal Canto, Elisa, et al.
Publicado: (2020)

Diet modification reverses diastolic dysfunction in rats with heart failure and preserved ejection fraction
por: Kim, Myung Yoon, et al.
Publicado: (2023)

Diastolic dysfunction in patients with preserved ejection fraction: identification by velocity encoded magnetic resonance imaging
por: Radunski, Ulf K, et al.
Publicado: (2011)

Left Atrial Size and Heart Failure Hospitalization in Patients with Diastolic Dysfunction and Preserved Ejection Fraction
por: Issa, Omar, et al.
Publicado: (2017)

Olmesartan reverses not only vascular endothelial dysfunction but cardiac diastolic dysfunction in hypertensive patients with heart failure with preserved ejection fraction — ORION study
por: Yamamoto, Eiichiro, et al.
Publicado: (2015)

Diastolic Ventricular Interaction in Heart Failure With Preserved Ejection Fraction
por: Parasuraman, Sathish K., et al.
Publicado: (2019)

Aortic stiffening precedes onset of heart failure with preserved ejection fraction in patients with asymptomatic diastolic dysfunction
por: Karagodin, Ilya, et al.
Publicado: (2017)

Association of serum total bilirubin levels with diastolic dysfunction in heart failure with preserved ejection fraction
por: Zheng, Huan, et al.
Publicado: (2014)

Myeloperoxidase, a possible biomarker for the early diagnosis of cardiac diastolic dysfunction with preserved ejection fraction
por: Coculescu, Bogdan Ioan, et al.
Publicado: (2018)

Risk Factors And Epigenetic Markers Of Left Ventricular Diastolic Dysfunction With Preserved Ejection Fraction In A Community-Based Elderly Chinese Population
por: Wang, Wei, et al.
Publicado: (2019)

Circulating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction
por: Chou, Ruey-Hsing, et al.
Publicado: (2016)

Is there a latent left ventricular dysfunction in hypertensive patients with preserved ejection fraction ?
por: Taamallah, Karima, et al.
Publicado: (2021)

Epicardial fat volume is inversely correlated with the degree of diastolic dysfunction and outcome in patients with heart failure with preserved ejection fraction
por: Karakus, Gültekin, et al.
Publicado: (2013)

Left Ventricular Torsion Shear Angle Volume Approach for Noninvasive Evaluation of Diastolic Dysfunction in Preserved Ejection Fraction
por: Sharifov, Oleg F., et al.
Publicado: (2017)

The effect of different anaesthetics on echocardiographic evaluation of diastolic dysfunction in a heart failure with preserved ejection fraction model
por: Cuijpers, Ilona, et al.
Publicado: (2020)

Electrocardiographic Features of Left Ventricular Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction: A Systematic Review
por: Van Ommen, Anne-Mar, et al.
Publicado: (2021)

Heart Failure with Preserved Left Ventricular Ejection Fraction: A Complex Conundrum Simply Not Limited to Diastolic Dysfunction
por: Lopez-Candales, Angel, et al.
Publicado: (2023)

Prognostic significance of diastolic blood pressure in patients with heart failure with preserved ejection fraction
por: Fuchida, Aya, et al.
Publicado: (2021)

Prognosis and diastolic dysfunction predictors in patients with heart failure and recovered ejection fraction
por: Takada, Takuma, et al.
Publicado: (2022)

Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction
por: van de Bovenkamp, Arno A., et al.
Publicado: (2021)

Left ventricular diastolic and systolic dyssynchrony and dysfunction in heart failure with preserved ejection fraction and a narrow QRS complex
por: Liu, Shuang, et al.
Publicado: (2018)

Overlap between angina without obstructive coronary artery disease and left ventricular diastolic dysfunction with preserved ejection fraction
por: Michelsen, Marie Mide, et al.
Publicado: (2019)

Natriuretic peptides for the detection of diastolic dysfunction and heart failure with preserved ejection fraction—a systematic review and meta-analysis
por: Remmelzwaal, Sharon, et al.
Publicado: (2020)

CXCR4-dependent macrophage-to-fibroblast signaling contributes to cardiac diastolic dysfunction in heart failure with preserved ejection fraction
por: Zhang, Ning, et al.
Publicado: (2022)

Long term development of diastolic dysfunction and heart failure with preserved left ventricular ejection fraction in heart transplant recipients
por: Vejpongsa, Pimprapa, et al.
Publicado: (2022)

High Neutrophil to Lymphocyte Ratio and Its Gene Signatures Correlate With Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction
por: Bai, Bo, et al.
Publicado: (2021)

Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction. Where to Draw the Line
por: Simon, Marc A., et al.
Publicado: (2019)

Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors
por: Ovchinnikov, Artem, et al.
Publicado: (2022)

Left atrial minimal volume: association with diastolic dysfunction and heart failure in patients in sinus rhythm or atrial fibrillation with preserved ejection fraction
por: Ben-Arzi, Assaf, et al.
Publicado: (2021)

Opportunistic screening models for high-risk men and women to detect diastolic dysfunction and heart failure with preserved ejection fraction in the community
por: Gohar, Aisha, et al.
Publicado: (2018)

Personalized pacing for diastolic dysfunction and heart failure with preserved ejection fraction: Design and rationale for the myPACE randomized controlled trial
por: Infeld, Margaret, et al.
Publicado: (2021)

Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
por: D’Amario, Domenico, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ihl1qea189cjcc4dbamc6tn55q